香港股市 已收市

健倍苗苗 (2161.HK)

HKSE - HKSE 延遲價格。貨幣為 HKD。
加入追蹤清單
0.900-0.010 (-1.10%)
收市:03:58PM HKT

健倍苗苗

Unit 808-811
C-Bons International Centre, 8th Floor 108 Wai Yip Street
Kwun Tong
Hong Kong
852 2267 2182
https://www.jbmhealthcare.com.hk

版塊Healthcare
行業Drug Manufacturers - Specialty & Generic
全職員工258

高階主管

名稱頭銜支付行使價出生年份
Mr. Yat Wai WongCEO & Executive Director2.81M1963
Mr. Kau Lap LamVP of Finance1986
Ms. Hoi Ki LeungOperation Manager1982
Ms. Chui Yee LoSenior Marketing Manager1969
Dr. Heung Kwan ChengExecutive Director1962
Mr. Chun Kau Yu ACS, FCPACompany Secretary1973
截止 2023年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

JBM (Healthcare) Limited, an investment holding company, engages in the manufacture, marketing, distribution, and sale of branded, healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally. It operates through Branded Medicines, Proprietary Chinese Medicines, and Health and Wellness Products segments. The Branded Medicines segment develops, manufactures, and distributes branded medicines with chemical compounds as active ingredients. The Proprietary Chinese Medicines segment develops, manufactures, and distributes registered Chinese medicines composed of Chinese herbal medicines. The Health and Wellness Products segment distributes and sells supplements, medical consumables, and other nonpharmaceutical products for the general health and wellness of consumers. The company offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and medicated and non-medicated solutions, as well as diagnostic devices. It is also involved in the trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong. JBM (Healthcare) Limited is a subsidiary of JBM Group (BVI) Limited.

公司管治

截至 無 止,健倍苗苗 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。